Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

BACKGROUND: There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). METHODS: We assessed the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:N Engl J Med
Huvudupphovsmän: Reynolds, Harmony R., Adhikari, Samrachana, Pulgarin, Claudia, Troxel, Andrea B., Iturrate, Eduardo, Johnson, Stephen B., Hausvater, Anaïs, Newman, Jonathan D., Berger, Jeffrey S., Bangalore, Sripal, Katz, Stuart D., Fishman, Glenn I., Kunichoff, Dennis, Chen, Yu, Ogedegbe, Gbenga, Hochman, Judith S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Massachusetts Medical Society 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206932/
https://ncbi.nlm.nih.gov/pubmed/32356628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2008975
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk